CorMedix Inc.

CorMedix Inc.
Stock Exchange NYSE
EPS
$1.18
Market Cap
$218.85 M
Shares Outstanding
23.8 M
Public Float
102.13 M
CorMedix Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
81.9 M
Public Float
78.13 M

Profile

Address
400 Connell Drive
Berkeley Heights New Jersey 07921
United States
Employees -
Website http://www.cormedix.com
Updated 07/08/2019
CorMedix, Inc. operates as a pharmaceutical and medical device company that seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The firm is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E.

Financials

View All

Myron Kaplan
Chairman
Mohammed Khoso Baluch
Chief Executive Officer & Director